Daan C.J. Brackel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Daan C.J. Brackel has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Chenay Waldekker
Researchgroup Analysis Techniques in the Life Sciences, Centre of Expertise Perspective in Health, Avans University of Applied Sciences, Breda, Netherlands
1 shared publication - Cindy M.A. de Bot
Researchgroup Prevention in Nursing, Centre of Expertise Perspective in Health, Avans University of Applied Sciences, Breda, Netherlands
1 shared publication - Eefje J.A. Schrauwen
Researchgroup Analysis Techniques in the Life Sciences, Centre of Expertise Perspective in Health, Avans University of Applied Sciences, Breda, Netherlands
1 shared publication - Eline Suzanne Klaassens
BaseClear B.V., Leiden, Netherlands
1 shared publication - Linda Wijnstroom-De Quartel
Molecular Biology Systems B.V., Goes, Netherlands
1 shared publication - Luena Pinheiro Keulers
Molecular Biology Systems B.V., Goes, Netherlands
1 shared publication
Latest Publications
- Open Access
Women’s health outreach using a rapid and fieldable Nanopore-based microbiome profiling workflow
Background: In recent years, scientific interest in the vaginal microbiome has increased due to its impact on women’s health. Colonization of the Lactobacillus species in the vagina may contribute to protection against vaginal infectious diseases. In order to create public awareness regarding vaginal health and to provide insights into the vaginal microbiome, a rapid field microbiome analysis using Nanopore sequencing was evaluated at Lowlands, a three-day music festival in the Netherlands. This study aimed not only to evaluate a rapid sequencing workflow, but also to explore citizen science as a tool for health promotion and public engagement in women’s health. Methods: The workflow at Lowlands contained the following steps; (i) Dialogue concerning vaginal health, with invitation to participate. (ii) Informed consent and questionnaire to investigate knowledge on vaginal health, life-style and contraceptive usage; (iii) self-collection of a vaginal swab; (iv) DNA isolation using QuickExtract DNA extraction solution; (v) Ultrafast amplification of the 16S rRNA gene using NextGenPCR™ thermal cycling using 16S Barcoding kit 24 V14; (vi) Library preparation and sequencing was performed according to the manufacturers protocol using R10 chemistry; (vii) For data-analysis, MABA16S was used, with slight modifications. This workflow was established within 4 hours and results were communicated with interested participants. Results: A total of n=303 people participated in this study within a timeframe of three days, with n=265 samples being analyzed. 35.8% of participants were dominated by L. crispatus , followed by L. iners (26.4%) and L. jensenii (6,4%). Additionally, lifestyle characteristics for Lactobacillus species carriership were investigated, with a statistically significant association found between dominance of Lactobacillus species and the contraceptive used. A knowledge gap was found regarding the awareness of Lactobacillus species in the vagina. Also, the project stimulated dialogue about vaginal health, with participants reporting that the study increased their awareness and ability to talk openly about the topic. Conclusions: This project successfully developed a rapid microbiome analysis capable of mapping the vaginal microbiome within four hours. Additionally, the findings highlight that citizen science-based research can effectively spark important conversations and may help break the taboo surrounding vaginal health. Clinical trial number: not applicable.
Open AccessWomen’s health outreach using a rapid and fieldable Nanopore-based microbiome profiling workflow
Background: In recent years, scientific interest in the vaginal microbiome has increased due to its impact on women’s health. Colonization of the Lactobacillus species in the vagina may contribute to protection against vaginal infectious diseases. In order to create public awareness regarding vaginal health and to provide insights into the vaginal microbiome, a rapid field microbiome analysis using Nanopore sequencing was evaluated at Lowlands, a three-day music festival in the Netherlands. This study aimed not only to evaluate a rapid sequencing workflow, but also to explore citizen science as a tool for health promotion and public engagement in women’s health. Methods: The workflow at Lowlands contained the following steps; (i) Dialogue concerning vaginal health, with invitation to participate. (ii) Informed consent and questionnaire to investigate knowledge on vaginal health, life-style and contraceptive usage; (iii) self-collection of a vaginal swab; (iv) DNA isolation using QuickExtract DNA extraction solution; (v) Ultrafast amplification of the 16S rRNA gene using NextGenPCR™ thermal cycling using 16S Barcoding kit 24 V14; (vi) Library preparation and sequencing was performed according to the manufacturers protocol using R10 chemistry; (vii) For data-analysis, MABA16S was used, with slight modifications. This workflow was established within 4 hours and results were communicated with interested participants. Results: A total of n=303 people participated in this study within a timeframe of three days, with n=265 samples being analyzed. 35.8% of participants were dominated by L. crispatus , followed by L. iners (26.4%) and L. jensenii (6,4%). Additionally, lifestyle characteristics for Lactobacillus species carriership were investigated, with a statistically significant association found between dominance of Lactobacillus species and the contraceptive used. A knowledge gap was found regarding the awareness of Lactobacillus species in the vagina. Also, the project stimulated dialogue about vaginal health, with participants reporting that the study increased their awareness and ability to talk openly about the topic. Conclusions: This project successfully developed a rapid microbiome analysis capable of mapping the vaginal microbiome within four hours. Additionally, the findings highlight that citizen science-based research can effectively spark important conversations and may help break the taboo surrounding vaginal health. Clinical trial number: not applicable.